DSS, Inc. (DSS) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

DSS, Inc. (DSS) Consumer Business Overview

DSS, Inc. is a diversified holding company operating in product packaging, biotechnology, and financial services. With a focus on acquiring undervalued assets and developing innovative solutions, DSS aims to create long-term shareholder value across multiple sectors, including alternative energy and digital transformation.

What Is the Investment Thesis for DSS?

DSS, Inc. presents a high-risk, high-reward investment opportunity due to its diversified business model and focus on acquiring undervalued assets. The company's ability to successfully integrate and scale its various business segments will be crucial for driving long-term growth. Key value drivers include the successful development and commercialization of its biotechnology investments, expansion of its financial services offerings, and growth in the alternative energy sector. However, the company's negative profit margin of -190.9% and gross margin of -4.4% indicate significant challenges in achieving profitability. Investors should closely monitor the company's ability to improve its financial performance and execute its growth strategy. The company's beta of 1.29 suggests higher volatility compared to the market.

Based on FMP financials and quantitative analysis

DSS Key Highlights

Market Cap of $7.54M reflects its small size within the Consumer Cyclical sector.

• P/E ratio of -0.20 indicates the company is currently unprofitable.
• Negative Profit Margin of -190.9% highlights significant challenges in achieving profitability.
• Negative Gross Margin of -4.4% suggests difficulties in managing production costs.
• Beta of 1.29 indicates higher volatility compared to the market average.

Who Are DSS's Competitors?

DSS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are DSS's Key Strengths?

Diversified business model across multiple sectors.

• Strategic focus on acquiring undervalued assets.
• Investments in high-growth industries like biotechnology and alternative energy.
• Experienced management team with expertise in various sectors.

What Are DSS's Weaknesses?

Negative profit and gross margins indicate financial challenges.

• Complex organizational structure due to diverse operations.
• Limited brand recognition compared to established competitors.
• Reliance on acquisitions for growth may pose integration risks.

What Could Drive DSS Stock Higher?

Potential breakthroughs in biotechnology research and development.

• Expansion of solar energy projects and partnerships.
• Integration of acquired companies and assets.
• Development of new and innovative product packaging solutions.
• Growth in the digital transformation sector.

What Are the Key Risks for DSS?

Financial-distress signal — its Altman Z-Score of -8.75 sits in the distress zone (elevated bankruptcy risk).

• Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 8 reported quarters.
• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Economic downturns may impact consumer spending and financial services.
• Regulatory changes in the biotechnology and financial sectors.
• Intense competition from established players in each industry.
• Technological advancements may disrupt existing business models.
• Financial challenges due to negative profit and gross margins.

What Are the Growth Opportunities for DSS?

• Expansion in Biotechnology: DSS's investments in the biohealth and biomedical fields present a significant growth opportunity. The company focuses on drug discovery and the prevention and treatment of neurological, oncological, and immune-related diseases. The global biotechnology market is projected to reach $3.87 trillion by 2030, offering substantial growth potential for DSS. Successful development and commercialization of new drugs and therapies could drive significant revenue growth.
• Growth in Alternative Energy: DSS's offerings in solar farms, solar battery banks, and residential energy creation and storage services align with the growing demand for renewable energy solutions. The global solar energy market is expected to reach $223.3 billion by 2031. DSS can capitalize on this trend by expanding its solar energy projects and partnerships, contributing to sustainable revenue growth.
• Digital Transformation Initiatives: DSS's involvement in digital transformation provides opportunities to enhance its existing businesses and develop new revenue streams. By leveraging digital technologies, DSS can improve operational efficiency, enhance customer experiences, and create innovative solutions for its clients.
• Strategic Acquisitions in Financial Services: DSS's strategy of acquiring equity positions in undervalued commercial banks and financial companies offers growth potential. The company focuses on providing loan syndication services, mortgage banking, and advisory capital raising services. By expanding its financial services offerings, DSS can generate additional revenue and diversify its business portfolio.
• Product Packaging Innovation: DSS's manufacturing and marketing of custom folding cartons, mailers, and photo sleeves provide a stable revenue stream. The company can drive growth by innovating its product packaging solutions and expanding its customer base. The global packaging market is expected to reach $1.2 trillion by 2027. DSS can capitalize on this trend by offering sustainable and innovative packaging solutions.

What Are DSS's Competitive Advantages?

• Diversified business model reduces reliance on any single industry.
• Strategic acquisitions of undervalued assets.
• Proprietary technologies in biotechnology and alternative energy.
• Established relationships with customers in various sectors.
• Expertise in identifying and developing growth opportunities.

What Does DSS Do?

DSS, Inc., formerly known as Document Security Systems, Inc., was founded in 1984 and is headquartered in West Henrietta, New York. Initially focused on document security solutions, the company has evolved into a diversified holding company with operations spanning product packaging, biotechnology, direct marketing, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy. In its product packaging segment, DSS manufactures and markets custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions. The company also markets and distributes nutritional and personal care products. DSS invests in and acquires companies in the biohealth and biomedical fields, focusing on drug discovery and the prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company also develops open-air defense initiatives for airborne infectious diseases. In the financial sector, DSS acquires equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies, offering services such as loan syndication, mortgage banking, and advisory capital raising. Additionally, DSS provides securities and investment management services, operates a real estate investment trust for healthcare facilities, and develops healthy living communities. The company also develops and acquires assets in securities trading, operates as a digital assets broker-dealer, and offers solar energy solutions.

What Products and Services Does DSS Offer?

• Manufactures and markets custom folding cartons and mailers.
• Distributes nutritional and personal care products.
• Invests in biohealth and biomedical companies.
• Develops open-air defense initiatives for airborne infectious diseases.
• Acquires equity positions in undervalued commercial banks.
• Provides securities and investment management services.
• Operates a real estate investment trust for healthcare facilities.
• Offers solar farms and battery storage solutions.

How Does DSS Make Money?

• Manufacturing and selling product packaging solutions.
• Investing in and acquiring companies in diverse sectors.
• Providing financial services, including lending and investment management.
• Developing and commercializing biotechnology products.
• Offering alternative energy solutions.

What Industry Does DSS Operate In?

DSS, Inc. operates in the Consumer Cyclical sector, which is sensitive to economic cycles and consumer spending patterns. The company's diverse operations span multiple industries, including packaging, biotechnology, and financial services. The packaging industry is driven by demand for consumer goods, while the biotechnology sector is characterized by high growth potential and significant R&D investments. The financial services industry is subject to regulatory changes and economic conditions. DSS faces competition from established players in each of these industries. Competitors include companies like ATER, CENN, FLYE, LOBO, and MRM.

Who Are DSS's Key Customers?

• Businesses requiring custom packaging solutions.
• Consumers of nutritional and personal care products.
• Patients and healthcare providers in the biohealth sector.
• Commercial banks and financial institutions.
• Investors seeking securities and investment management services.

Company Profile

DSS, Inc. operates in the Packaging & Containers industry within the Consumer Cyclical sector. It is headquartered in West Henrietta, US. The company is led by CEO Jason T. Grady. DSS has traded publicly since 1994.

DSS, Inc. Financial Trajectory

DSS, Inc. (DSS) reported $3.6M in revenue for Q2 FY2026, a decline of 16.8% compared to the prior quarter. The company recorded a net loss of $4.8M, with diluted EPS of $-0.48. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Cyclical. Across the four most recent quarters, DSS averaged $-0.74 in diluted EPS.

How DSS, Inc. Is Valued

DSS, Inc. carries a market capitalization of $7.54M, placing it in the micro-cap category. Relative to its peer group, DSS's quantitative score of 18/100 is below the peer average of 44/100.

Key Financial Metrics

Return on assets is -35.1%, showing how much profit it generates from its asset base. A current ratio of 0.22 means current liabilities exceed short-term assets, a liquidity point worth watching.

DSS, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -8.75 places it in the distress zone, a signal of elevated financial risk.

DSS, Inc. has missed Wall Street's EPS estimate in 4 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 108.3% below estimates on average.

Over the past six months, DSS, Inc. insiders filed 2 SEC Form 4 transactions — 0 sales and 2 purchases. On net that is roughly 16.6M shares acquired (about $0) — insiders putting money in tends to read as conviction.

DSS Financials

DSS Latest News

DSS Analyst Consensus

DSS MoonshotScore

Latest DSS, Inc. Analysis

DSS Consumer Cyclical Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources